Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

AT-31 BIO Inc.

other

www.at31bio.comDaegu, South Korea

About

AT-31 BIO Inc. aims to discover new drug candidates and develop innovative drugs that contribute to a healthy, happy society by overcoming diseases caused by dysfunctional immune systems. Currently, we are conducting empirical studies using cutting-edge research techniques on the immunosuppressive efficacy. We are also conducting preclinical studies using animal disease models to explore and establish indications for our potential drug candidates. Through these research approaches, we hope to open new horizons in the prevention and treatment of autoimmune diseases, transplant rejection, and hypersensitivity immune diseases, which represent unmet medical needs.

What is your business/industry sector?

Biotech, Pharma and Cosmetics

Representatives

Do Youn Chun

Chief Technical Officer

AT-31 BIO Inc.